Cambridge Investment Research Advisors, Inc. Geron Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Geron Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 163,990 shares of GERN stock, worth $206,627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163,990
Previous 176,490
7.08%
Holding current value
$206,627
Previous $625,000
58.24%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding GERN
# of Institutions
295Shares Held
500MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$76.1 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$58.7 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$48.1 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$43 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$34.3 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $476M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...